查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1974927

2026-2034年全球早产及胎膜早破（PROM）检测市场规模、份额、趋势及成长分析报告

Global Preterm Birth And PROM Testing Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 123 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计早产和胎膜早破 (PROM) 检测的市场规模将从 2025 年的 23.6 亿美元增长到 2034 年的 50.6 亿美元，2026 年至 2034 年的复合年增长率为 8.86%。

随着早期发现胎膜早破（PROM）和早产风险成为孕产妇保健的重中之重，全球早产和胎膜早破检测市场正在成长。这些情况会显着增加新生儿发病率和医疗保健成本。能够识别生物标记、感染标记或胎膜变化的诊断测试有助于临床医生更早进行干预，从而改善母婴结果。

全球出生率上升和新兴市场产前保健基础设施的不断完善，推动了对可靠检测套组的需求。医疗机构正在将先进的筛检通讯协定纳入常规产前检查。医疗服务的可近性提高和公众意识的增强，促使更多女性及时接受产前检查。

生物技术的进步提高了检测的准确性和速度，因此未来前景光明。就地检验和非侵入性检测技术的开发将进一步扩大其应用范围。与远端医疗服务的整合有望改善远距孕产妇监测。持续投入研发和临床检验将维持市场成长。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章：全球早产和胎膜早破（PROM）检测市场：依检测类型划分

  • 市场分析、洞察与预测
  • 骨盆腔检查
  • 超音波检查
  • 生化标记
  • 子宫监测
  • 尼他定试验
  • 蕨状结晶试验
  • 池化方法
  • PAMG-1免疫检测
  • IGFBP检测
  • 胎儿纤维黏附蛋白（fFn）
  • 其他的

第五章 全球早产和胎膜早破 (PROM) 检测市场：按最终用户划分

  • 市场分析、洞察与预测
  • 医院
  • 诊断检查室
  • 门诊部
  • 研究机构
  • 其他的

第六章 全球早产和胎膜早破 (PROM) 检测市场：按地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第七章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴（根据现有资讯）
  • 市场占有率和市场定位分析（基于现有资讯）
  • 供应商情况（基于现有资讯）
  • 策略规划

第八章：公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Qiagen NV
    • Hologic Inc
    • Cooper Surgical Inc
    • Abbott
    • Medixbiochemica
    • Sera Prognostics
    • Clinical Innovations LLC
    • Biosynex
    • NX Prenatal Inc
    • IQ Products
简介目录
Product Code: VMR11211146

The Preterm Birth And PROM Testing Market size is expected to reach USD 5.06 Billion in 2034 from USD 2.36 Billion (2025) growing at a CAGR of 8.86% during 2026-2034.

The Global Preterm Birth and PROM Testing Market is growing as maternal healthcare prioritizes early detection of premature rupture of membranes (PROM) and preterm labor risk. These conditions contribute significantly to neonatal morbidity and healthcare costs. Diagnostic tests that identify biomarkers, infection markers, or membrane changes help clinicians intervene earlier to improve maternal and fetal outcomes.

Rising global birth rates and expanding prenatal care infrastructure in emerging markets increase demand for reliable testing kits. Healthcare providers are adopting advanced screening protocols as part of routine prenatal evaluations. Improved accessibility and awareness are encouraging women to seek timely prenatal assessments.

Future prospects look positive as biotechnology advances refine test accuracy and speed. Development of point-of-care and noninvasive testing options will broaden adoption. Integration with telehealth services could improve remote maternal monitoring. Continued investment into research and clinical validation will sustain market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Type

  • Pelvic Exam
  • Ultrasound
  • Biochemical Markers
  • Uterine Monitoring
  • Nitazine Test
  • Ferning Test
  • Pooling
  • Pamg-1 Immunoassay
  • IGFBP Test
  • Fetal Fibronectin (fFn)
  • Others

By End User

  • Hospitals
  • Diagnostics Laboratories
  • Outpatient Clinics
  • Research Centers
  • Others

COMPANIES PROFILED

  • Qiagen NV, Hologic Inc, Cooper Surgical Inc, Abbott, Medixbiochemica, Sera prognostics, Clinical Innovations LLC, Biosynex, NX Prenatal Inc, IQ Products
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL PRETERM BIRTH AND PROM TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Test Type
  • 4.2. Pelvic Exam Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Ultrasound Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Biochemical Markers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Uterine Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Nitazine Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. Ferning Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. Pooling Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.9. Pamg-1 Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.10. IGFBP Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.11. Fetal Fibronectin (fFn) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.12. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PRETERM BIRTH AND PROM TESTING MARKET: BY END USER 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End User
  • 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Outpatient Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Research Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PRETERM BIRTH AND PROM TESTING MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Test Type
    • 6.2.2 By End User
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Test Type
    • 6.3.2 By End User
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Test Type
    • 6.4.2 By End User
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Test Type
    • 6.5.2 By End User
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Test Type
    • 6.6.2 By End User
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL PRETERM BIRTH AND PROM TESTING INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Qiagen N.V
    • 8.2.2 Hologic Inc
    • 8.2.3 Cooper Surgical Inc
    • 8.2.4 Abbott
    • 8.2.5 Medixbiochemica
    • 8.2.6 Sera Prognostics
    • 8.2.7 Clinical Innovations LLC
    • 8.2.8 Biosynex
    • 8.2.9 NX Prenatal Inc
    • 8.2.10 IQ Products